J. Winner

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.

C. Altar, B. DeChairo, Josiah D. Allen, 2013, Discovery medicine.

Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility

B. DeChairo, J. Winner, Joel G. Winner, 2015, The Yale journal of biology and medicine.

Overwhelmed by Side Effects

J. Winner, Joel G. Winner, 2012 .

Training in Psychiatric Genomics During Residency: A New Challenge

D. Mrazek, D. Goebert, C. Matsu, 2010, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.

Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies

C. Altar, B. DeChairo, D. Hall‐Flavin, 2015, Molecular Neuropsychiatry.

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting

D. Mrazek, M. Drews, K. Snyder, 2013, Pharmacogenetics and genomics.

Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation

C. Altar, S. Garavaglia, G. Lavezzari, 2015, Current medical research and opinion.

Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes

C. Altar, B. DeChairo, D. Hall‐Flavin, 2015, The Pharmacogenomics Journal.

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression

C. Altar, Josiah D. Allen, J. Winner, 2013, Translational Psychiatry.

Using a pharmacogenomic algorithm to guide the treatment of depression

J. Biernacka, D. Mrazek, M. Drews, 2012, Translational Psychiatry.

Analytical validation of a psychiatric pharmacogenomic test.

B. DeChairo, L. Watterson, S. Gunselman, 2018, Personalized medicine.

The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes

Michael R. Jablonski, Josiah D. Allen, J. Winner, 2015, Applied & translational genomics.

Use of combinatorial pharmacogenomic testing in two cases from community psychiatry

Raymond A. Lorenz, J. Winner, Eve S Fields, 2016, Pharmacogenomics and personalized medicine.

Supplementary Material for: Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies

C. Altar, B. DeChairo, D. Hall‐Flavin, 2016 .